Lacey, WA – January 10, 2006 – Unigen Pharmaceuticals, Inc., a leading research and development facility and supplier of proprietary, biologically active plant-derived ingredients to the natural products and pharmaceutical industries, has announced the launch of Soliprin™, a science-based all-natural skin care product.
Product development involved the screening of 1,230 plant extracts in order to discover natural botanical compounds with the promise of helping protect skin exposed to UV radiation, and internal and environmental toxins. Unigen launched Soliprin™ at the recently held 9th Annual SupplySide West International Trade Show and Conference in Las Vegas.
“Millions of people in the modern world are plagued with a host of concerns that challenge their skin looking healthy and at its best,” said Dr. Qi Jia, Unigen’s Chief Scientific Officer. “Exposure to ultraviolet radiation, toxic chemicals and air pollution are hard to avoid, and the emotional stress of our fast-paced lives can also contribute to skin aging. Consequently, Unigen is excited to launch a safe product that can help protect the skin and promote a youthful appearance.”
Soliprin™ is a blend of two novel plant extracts that have been tested using gene expression, protein inhibition assays, cell-based studies and human clinical trials to provide potent antioxidant activities with an Oxygen Radical Absorbance Capacity (ORAC) value higher than 19,000, which reflects a potency approximately four-fold that of vitamin C.
The product has also been shown to modulate prostaglandin and leukotriene pathways and down-regulate cytokine gene expression, resulting in reduction of skin inflammation and an increase of Minimum Erythema Dosage (MED) on humans. Soliprin topical formulations at 0.5% and 1.5% concentrations showed no irritation, sensitization and phototoxicity in human clinical safety trials.
Marcus Laux, Chairman of Unigen’s Scientific Advisory Board and a licensed naturopathic physician, featured Soliprin at a SupplySide West VendorWorks Presentation and highlighted the product’s ability to support healthy aging for the skin and to address minor skin irritation due to the product’s potent antioxidant activities.
# # #
About Unigen Pharmaceuticals, Inc.
Unigen Pharmaceuticals, Inc. (www.UnigenPharma.com) is a leading natural products research and development company and proprietary ingredients supplier. The company is dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve the quality of human life. Its research and discovery process includes extensive work at both the human cell and gene level. Unigen and sister company Aloecorp, Inc. each focus on identifying and studying the unique ingredients of medicinal botanicals (Aloecorp’s focus is on Aloe vera) and then formulating proprietary, patented raw materials for use in cosmeceutical, nutraceutical and pharmaceutical products.
Regan Miles, President & Chief Operating Officer